Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.40 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.40 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 2/20 | 0.40 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.40 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.40 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.40 |
| ▸ | ADRB2 | P07550 | 3/20 | 0.36 |
| ▸ | ADRB3 | P13945 | 3/20 | 0.36 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.36 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.36 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.36 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.36 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.36 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.35 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.35 |
| ▸ | HTR1B | P28222 | 4/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25533342 | 1.00 | TAAR1 (0.40) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533181 | 0.88 | TAAR1 (0.40) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533326 | 0.88 | TAAR1 (0.40) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533321 | 0.80 | SIGMAR1 (0.46) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533176 | 0.80 | SIGMAR1 (0.46) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533194 | 0.79 | TAAR1 (0.67) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533340 | 0.79 | TAAR1 (0.67) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533453 | 0.76 | ALOX15 (0.49) | TAAR1SLC6A2SLC6A4SLC6A3CYP2D6 | |
| SCHEMBL25533494 | 0.76 | TAAR1 (0.57) | TAAR1SLC6A2SLC6A4SLC6A3ALOX15 | |
| SCHEMBL26060350 | 0.76 | TAAR1 (0.57) | TAAR1SLC6A2SLC6A4SLC6A3ALOX15 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230150966-A1 | ISOTOPICALLY ENRICHED 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE) AND STEREOISOMERS THEREOF | TERRAN BIOSCIENCES INC (US) | 2023-05-18 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230150966-A1 | ISOTOPICALLY ENRICHED 3,4-METHYLENEDIOXY-N-ETHYLAMPHETAMINE (MDE) AND STEREOISOMERS THEREOF | SLC6A3, DBH, PNMT | TAAR1 103/4885SLC6A2 10/4885SLC6A4 12/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.